English
SALUGGIA (VC) and BREA, Calif. (USA) — (August 30, 2016) — DiaSorin (FTSE Italia Mid Cap: DIA), a global leader in in vitro diagnostics immunoassay specialty testing, and Beckman Coulter Diagnostics, a global developer and manufacturer of clinical diagnostic products, are pleased to announce an agreement to provide customers in the U.S. the LIAISON XL Hepatitis A, B, C and HIV products currently available to DiaSorin customers outside the U.S. territory. The two companies will work together to submit the products to the Food and Drug Administration (FDA) for approval and commercialization in the U.S.
Once cleared, Beckman Coulter and DiaSorin intend to offer U.S. customers access to the full line of Hepatitis and HIV products that can be run on the LIAISON XL LAS connected to Beckman Coulter's leading automation solutions, the Power Express and Power Processor automated processing systems. According to the agreement, DiaSorin will retain the right to commercialize the products on LIAISON XL stand-alone systems, to pursue its strategy of penetrating the lower volume hospital labs where total laboratory automation (TLA) is not required.
DiaSorin estimates that the total available U.S. market for these products, excluding blood bank testing, exceeds U.S. $500 million.
"After the successful agreement we already signed in China, I'm very proud that Beckman Coulter choose to extend the partnership with us to the U.S. market," commented Carlo Rosa, CEO of DiaSorin Group. "Our complete menu of Hepatitis and HIV products available on the LIAISON XL coupled with the Beckman Coulter leadership in the TLA market will offer our customers an ideal solution to address the issues created in the labs by the increase of testing volume related to the ongoing consolidation of testing sites."
"Beckman Coulter and DiaSorin have been working successfully together in China since late last year, helping our customers improve their operations in this key testing area. This new agreement is a natural extension of that partnership. Beckman Coulter is very pleased to be working so close with DiaSorin to bring to our customers solutions for their laboratories," said Arnd Kaldowski, president, Beckman Coulter Diagnostics.
Choose your country/region and language
Your experience may change as only information for the country or region you select will be presented.
